Adverum Biotechnologies

PulseSight Therapeutics

This company develops non-viral gene therapies for patients with severe eye diseases including age-related macular degeneration.

Beacon Therapeutics

This company develops ophthalmic gene therapies to restore vision for patients with rare and prevalent retinal diseases causing blindness.

Iveric Bio

This biopharmaceutical company develops therapeutic treatments for retinal diseases and provides these medicines to patients with age-related macular degeneration and inherited conditions.

EyeBio

This biotechnology company develops ocular therapies to treat retinal diseases such as diabetic macular edema and age-related macular degeneration for patients with vision loss.

Atsena

This clinical-stage gene therapy company develops genetic medicines to reverse or prevent blindness for patients with inherited retinal diseases.

Cirrus Therapeutics

This company develops gene and cell therapies to treat age-related macular degeneration and chronic vision loss for patients with blinding eye diseases.

Vedere

The company develops optogenetics-based gene therapies to restore vision for patients with inherited retinal dystrophies and geographic atrophy.

Atsena Therapeutics

This clinical-stage company develops gene therapies to treat and prevent inherited retinal diseases for patients with conditions such as X-linked retinoschisis and Stargardt disease.